Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
450 participants
INTERVENTIONAL
2025-08-20
2026-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Model Description: Cluster-randomized by preceptor (30 clusters; 15 OMP/15 control). Outcomes at student level; 15 students per cluster.
Adequate OMP exposure is defined a priori as ≥2 structured OMP feedback encounters (≥5 minutes each) delivered across ≥2 separate weeks of the rotation.
Masking: Outcomes Assessor
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OMP
One-Minute Preceptor training: 90-min workshop + pocket card + coaching + fidelity checklist.
One-Minute Preceptor (OMP)
Faculty development workshop (90 min), pocket card, coaching, audit with OMP 5-step fidelity checklist.
Control
Usual bedside teaching; OMP offered after trial completion.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
One-Minute Preceptor (OMP)
Faculty development workshop (90 min), pocket card, coaching, audit with OMP 5-step fidelity checklist.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Aged ≥18 years at enrollment.
Enrolled Year 4-medical students assigned to one of the participating preceptor-led bedside teaching groups during the study period.
Expected to attend the rotation for 8-12 weeks (or the site's standard rotation length).
Able to provide informed consent (and agree to be observed/assessed via mini-CEX).
\- B. Preceptor clusters (randomized units):
Resident physicians serving as bedside teaching preceptors in participating departments.
Will supervise approximately 15 students during the study period.
Agree not to cross over to teach students in the opposite trial arm during the trial period.
Able to attend OMP training and permit fidelity observation (checklist) if allocated to the intervention.
Exclusion Criteria
Prior exposure to formal OMP-based teaching within the past 6 months in the same department.
Not expected to remain on the rotation long enough to be assessed (e.g., planned absence \>2 weeks or early withdrawal).
Declines or withdraws informed consent.
Severe communication barrier that precludes valid assessment (e.g., language barrier without support).
\- B. Preceptor clusters:
Formal OMP training within the past 12 months (to avoid contamination), or role as an OMP trainer for other faculty during the study period.
Planned cross-coverage that would result in teaching students from both arms during the trial period.
Anticipated extended leave making fidelity and outcome assessments infeasible.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Can Tho University of Medicine and Pharmacy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Quang C Ngo
Role: STUDY_CHAIR
Can Tho University Medicine and Pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Can Tho Children Hospital
Can Tho, Province, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Quang C Ngo
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1925/QĐ-ĐHYDCT/07
Identifier Type: -
Identifier Source: org_study_id